SUMMERVILLE, Ga. — When children battling cancer are granted a wish, many dream about a trip, meeting a favorite celebrity or doing something unforgettable after months of painful treatments. But when ...
Clinical Trials Arena on MSN
Storm clinches $56m in Series C for Phase II on lead sarcoma drug
The Pfizer-backed Series C round will see Storm work out an accelerated approval pathway for STC-15 in sarcoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results